Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Main Capital and Björn Lundén in connection with their acquisition of TimeKeeper
Mandate

Vinge advises Main Capital and Björn Lundén in connection with their acquisition of TimeKeeper

November 29, 2021 Employment and Benefits Intellectual Property M&A

TimeKeeper is a solution for time, project and expense management. Through the acquisition, Björn Lundén strengthens its solution offering which now includes a new time and project management functionality. The combined Björn Lundén offering creates a one-stop-shop for accounting and financial management.

Vinge’s team consisted of Filip Öhrner and Olivia Belding (M&A), Ebba Svenburg (Employment) and Klara Secher (IP).

 

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026